In breast cancer, carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), and cancer antigen 15‐3 (CA15‐3) are widely used, but their predictive value remains suboptimal [14]. This evidence concerns the gene CEACAM5 and breast carcinoma.